Navegar por los elementos (20655 total)
Ordenar por:
Reply to Dorgham et al., Considering Personalized Interferon Beta Therapy for COVID-19"."
Position: 15820 (24 views)
Reply to Focusing COVID-19 vaccinations on elderly and high-risk people"."
Position: 14966 (25 views)
Reply to Integral management of COVID-19 in Madrid: Turning things around during the second wave"."
Position: 16643 (23 views)
Reply to Letter to the Editor, Reply to Yasri & Wiwanitkit.
Position: 18088 (21 views)
Reply to letter to the editor: A response to 'Male balding is a major risk factor for severe COVID-19'"."
Position: 8101 (34 views)
Reply to Steinmaurer and Bley.
Position: 4921 (42 views)
Reply to the letter.
Position: 11511 (29 views)
Reply to Yang et al.: Tocilizumab treatment in COVID-19 patients needs the assessment of the disease severity and timely intervention.
Position: 14966 (25 views)
Reply to: Asymptomatic infection by SARS 2 coronavirus: invisible but invincible.
Position: 18088 (21 views)
